P072 Prognostic role of FDG-PET in clinical management of Hodgkin lymphoma patients with residual mass – long term follow-up

2007 ◽  
Vol 31 ◽  
pp. S96
Author(s):  
I. Marton ◽  
Zs. Molnár ◽  
Z. Borbényi ◽  
L. Galuska ◽  
K. Keresztes ◽  
...  
1998 ◽  
Vol 16 (4) ◽  
pp. 1363-1366 ◽  
Author(s):  
R Zucali ◽  
L Mariani ◽  
E Marubini ◽  
R Kenda ◽  
L Lozza ◽  
...  

PURPOSE The prognostic role of the site of the primary breast cancer has not been clarified. This study aimed to gather more information about this issue from a large series of patients with long-term follow-up data. PATIENTS AND METHODS Data from 2,396 patients treated for early breast cancer with a conservative approach were reviewed (1973 to 1989). In 1,619 patients, the tumor had a lateral site, while in 777 cases, it was situated in the internal/central quadrants. The characteristics of the two groups were well balanced, apart from axillary nodal metastases, which were more frequent for lateral tumors (38.1% v 26.3%). RESULTS Analysis of distant metastases indicated that the regression coefficient associated with tumor site was significant and the hazards ratio estimate was 1.291, which indicates the risk of distant metastases was increased by approximately 30% for internal/central tumors. The analysis of overall survival yielded a significant coefficient and a hazards ratio of 1.192, which indicates an approximately 20% increase of mortality for internal/central tumors. CONCLUSION Early breast cancers situated in central/ internal quadrants have a worse prognosis compared with those in lateral quadrants, in terms of distant metastases and survival. Irradiation of the internal mammary chain for internal/medial tumors could be suggested, but, to date, the therapeutic strategy is still controversial.


Blood Reviews ◽  
2007 ◽  
Vol 21 ◽  
pp. S84 ◽  
Author(s):  
Zs. Molnár ◽  
Z. Borbényi ◽  
L. Galuska ◽  
K. Keresztes ◽  
I. Marton ◽  
...  

1999 ◽  
Vol 246 (9) ◽  
pp. 770-775 ◽  
Author(s):  
A. Ghezzi ◽  
V. Martinelli ◽  
V. Torri ◽  
M. Zaffaroni ◽  
M. Rodegher ◽  
...  

2016 ◽  
Vol 44 (2) ◽  
pp. 352-352
Author(s):  
Maddalena Sansovini ◽  
Stefano Severi ◽  
Annarita Ianniello ◽  
Silvia Nicolini ◽  
Lorenzo Fantini ◽  
...  
Keyword(s):  
Fdg Pet ◽  

2001 ◽  
Vol 8 (1) ◽  
pp. S86-S86
Author(s):  
P ZANCO ◽  
A DESIDERI ◽  
C CERNETTI ◽  
S MODARRESL ◽  
E MILAN ◽  
...  

2016 ◽  
Vol 44 (3) ◽  
pp. 490-499 ◽  
Author(s):  
Maddalena Sansovini ◽  
Stefano Severi ◽  
Annarita Ianniello ◽  
Silvia Nicolini ◽  
Lorenzo Fantini ◽  
...  
Keyword(s):  
Fdg Pet ◽  

2013 ◽  
Author(s):  
Francesca Menegazzo ◽  
Melissa Rosa Rizzotto ◽  
Martina Bua ◽  
Luisa Pinello ◽  
Elisabetta Tono ◽  
...  

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Francesco Santoro ◽  
Tecla Zimotti ◽  
Adriana Mallardi ◽  
Alessandra Leopizzi ◽  
Enrica Vitale ◽  
...  

AbstractTakotsubo syndrome (TTS) is an acute heart failure syndrome with significant rates of in and out-of-hospital mayor cardiac adverse events (MACE). To evaluate the possible role of neoplastic biomarkers [CA-15.3, CA-19.9 and Carcinoembryonic Antigen (CEA)] as prognostic marker at short- and long-term follow-up in subjects with TTS. Ninety consecutive subjects with TTS were enrolled and followed for a median of 3 years. Circulating levels of CA-15.3, CA-19.9 and CEA were evaluated at admission, after 72 h and at discharge. Incidence of MACE during hospitalization and follow-up were recorded. Forty-three (46%) patients experienced MACE during hospitalization. These patients had increased admission levels of CEA (4.3 ± 6.2 vs. 2.2 ± 1.5 ng/mL, p = 0.03). CEA levels were higher in subjects with in-hospital MACE. At long term follow-up, CEA and CA-19.9 levels were associated with increased risk of death (log rank p < 0.01, HR = 5.3, 95% CI 1.9–14.8, HR = 7.8 95% CI 2.4–25.1, respectively, p < 0.01). At multivariable analysis levels higher than median of CEA, CA-19.9 or both were independent predictors of death at long term (Log-Rank p < 0.01). Having both CEA and CA-19.9 levels above median (> 2 ng/mL, > 8 UI/mL respectively) was associated with an increased risk of mortality of 11.8 (95% CI 2.6–52.5, p = 0.001) at follow up. Increased CEA and CA-19.9 serum levels are associated with higher risk of death at long-term follow up in patients with TTS. CEA serum levels are correlated with in-hospital MACE.


Sign in / Sign up

Export Citation Format

Share Document